CD4 testing rates over 6 months improved from 43% to 78% in 1 setting35 and from 10.8% to 20.5% when testing individuals on enrollment and after 6 months of follow-up.41 However, there were not always substantial gains or improvements.25 Prophylaxis access for opportunistic infections also increased. The gene discussed is CD4; the disease is Opportunistic infection.